Contact Us
Drug Search Results
Using advanced filters...
Advanced Search [+]

BNT-114

Alternative Names: bnt-114, bnt 114, bnt114
Latest Update: 2021-08-09
Latest Update Note: News Article

Product Description

BioNTech is developing BNT-114 as a treatment for triple negative breast cancer. (Sourced from: https://investors.biontech.de/static-files/5fe7c487-7eb9-4ecd-91f8-0a4cb47d8d1c)

Mechanisms of Action: Vaccine

Novel Mechanism: No

Modality: Vaccine

Route of Administration: Injection

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: BioNTech
Company Location: MAINZ 2M 55131
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 1: Triple Negative Breast Cancer

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title

08/09/2021

News Article

 BioNTech Announces Second Quarter 2021 Financial Results and Corporate Update

08/11/2020

News Article

 BioNTech Announces Second Quarter 2020 Financial Results and Corporate Progress

07/30/2020

News Article

 BioNTech Publishes Data from mRNA-based BNT111 FixVac Melanoma Trial in Nature

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions